• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

手术后症状性静脉血栓栓塞的时间:荟萃分析。

Timing of symptomatic venous thromboembolism after surgery: meta-analysis.

机构信息

Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland.

出版信息

Br J Surg. 2023 Apr 12;110(5):553-561. doi: 10.1093/bjs/znad035.

DOI:10.1093/bjs/znad035
PMID:36912116
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10364527/
Abstract

BACKGROUND

The timing at which venous thromboembolism (VTE) occurs after major surgery has major implications for the optimal duration of thromboprophylaxis. The aim of this study was to perform a systematic review and meta-analysis of the timing of postoperative VTE up to 4 weeks after surgery.

METHODS

A systematic search of MEDLINE, Scopus, and CINAHL databases was performed between 1 January 2009 and 1 April 2022. Prospective studies that recruited patients who underwent a surgical procedure and reported at least 20 symptomatic, postoperative VTE events by time were included. Two reviewers independently selected studies according to the eligibility criteria, extracted data, and evaluated risk of bias. Data were analysed with a Poisson regression model, and the GRADE approach was used to rate the certainty of evidence.

RESULTS

Some 6258 studies were evaluated, of which 22 (11 general, 5 urological, 4 mixed, and 2 orthopaedic postoperative surgical populations; total 1 864 875 patients and 24 927 VTE events) were eligible. Pooled evidence of moderate certainty showed that 47.1 per cent of the VTE events occurred during the first, 26.9 per cent during the second, 15.8 per cent during the third, and 10.1 per cent during the fourth week after surgery. The timing of VTE was consistent between individual studies.

CONCLUSION

Although nearly half of symptomatic VTE events in first 4 weeks occur during the first postoperative week, a substantial number of events occur several weeks after surgery. These data will inform clinicians and guideline developers about the duration of postoperative thromboprophylaxis.

摘要

背景

静脉血栓栓塞症(VTE)在大手术后发生的时间对最佳血栓预防持续时间有重大影响。本研究的目的是对手术后 4 周内术后 VTE 的发生时间进行系统回顾和荟萃分析。

方法

对 MEDLINE、Scopus 和 CINAHL 数据库进行了 2009 年 1 月 1 日至 2022 年 4 月 1 日的系统检索。纳入了招募接受手术且至少报告 20 例有症状、术后 VTE 事件的前瞻性研究。两名审查员根据纳入标准独立选择研究、提取数据和评估偏倚风险。使用泊松回归模型进行数据分析,并使用 GRADE 方法对证据确定性进行评级。

结果

共评估了 6258 项研究,其中 22 项(11 项普通外科、5 项泌尿科、4 项混合外科和 2 项矫形外科术后手术人群;总计 1864875 例患者和 24927 例 VTE 事件)符合条件。中等确定性的汇总证据表明,47.1%的 VTE 事件发生在术后第 1 周,26.9%发生在第 2 周,15.8%发生在第 3 周,10.1%发生在第 4 周。各研究之间 VTE 的发生时间是一致的。

结论

尽管 4 周内近一半的有症状 VTE 事件发生在术后第 1 周内,但仍有相当数量的事件发生在手术后数周。这些数据将为临床医生和指南制定者提供关于术后血栓预防持续时间的信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e598/10364527/06b1f1d578f0/znad035f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e598/10364527/d1d10175c9a4/znad035f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e598/10364527/5929e2c2fbae/znad035f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e598/10364527/06b1f1d578f0/znad035f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e598/10364527/d1d10175c9a4/znad035f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e598/10364527/5929e2c2fbae/znad035f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e598/10364527/06b1f1d578f0/znad035f3.jpg

相似文献

1
Timing of symptomatic venous thromboembolism after surgery: meta-analysis.手术后症状性静脉血栓栓塞的时间:荟萃分析。
Br J Surg. 2023 Apr 12;110(5):553-561. doi: 10.1093/bjs/znad035.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Compression stockings in addition to low-molecular-weight heparin to prevent venous thromboembolism in surgical inpatients requiring pharmacoprophylaxis: the GAPS non-inferiority RCT.加压弹力袜联合低分子肝素预防需药物预防的住院手术患者静脉血栓栓塞症:GAPS 非劣效 RCT 研究。
Health Technol Assess. 2020 Dec;24(69):1-80. doi: 10.3310/hta24690.
4
Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism.对有静脉血栓栓塞风险的住院患者实施血栓预防的干预措施。
Cochrane Database Syst Rev. 2018 Apr 24;4(4):CD008201. doi: 10.1002/14651858.CD008201.pub3.
5
Procedure-specific Risks of Thrombosis and Bleeding in Urological Cancer Surgery: Systematic Review and Meta-analysis.泌尿外科癌症手术中血栓形成和出血的特定程序风险:系统评价和荟萃分析。
Eur Urol. 2018 Feb;73(2):242-251. doi: 10.1016/j.eururo.2017.03.008. Epub 2017 Mar 23.
6
Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia.成人急性淋巴细胞白血病患者使用门冬酰胺酶治疗期间血栓栓塞的预防
Cochrane Database Syst Rev. 2020 Oct 10;10(10):CD013399. doi: 10.1002/14651858.CD013399.pub2.
7
Systematic reviews of observational studies of Risk of Thrombosis and Bleeding in General and Gynecologic Surgery (ROTBIGGS): introduction and methodology.普通外科和妇科手术中血栓形成与出血风险的观察性研究的系统评价(ROTBIGGS):引言与方法
Syst Rev. 2021 Oct 8;10(1):264. doi: 10.1186/s13643-021-01814-2.
8
Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer.癌症患者静脉血栓栓塞症长期治疗的抗凝治疗
Cochrane Database Syst Rev. 2018 Jun 19;6(6):CD006650. doi: 10.1002/14651858.CD006650.pub5.
9
Interventions for implementation of thromboprophylaxis in hospitalized medical and surgical patients at risk for venous thromboembolism.对有静脉血栓栓塞风险的住院内科和外科患者实施血栓预防的干预措施。
Cochrane Database Syst Rev. 2013 Jul 16(7):CD008201. doi: 10.1002/14651858.CD008201.pub2.
10
Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis.首次无诱因静脉血栓栓塞事件停止抗凝治疗后症状性复发性静脉血栓栓塞的长期风险:系统评价和荟萃分析。
BMJ. 2019 Jul 24;366:l4363. doi: 10.1136/bmj.l4363.

引用本文的文献

1
Influence of patient's weight and body mass index on presentation, time of onset, and impact of postoperative venous thromboembolism (RIETE registry).患者体重和体重指数对术后静脉血栓栓塞症的表现、发病时间及影响的作用(RIETE注册研究)
J Thromb Thrombolysis. 2025 Jun 28. doi: 10.1007/s11239-025-03126-x.
2
Development and validation of a nomogram prediction model for perioperative deep vein thrombosis risk in arthroplasty: a retrospective study.关节置换术中围手术期深静脉血栓形成风险列线图预测模型的构建与验证:一项回顾性研究
Front Med (Lausanne). 2025 May 22;12:1528154. doi: 10.3389/fmed.2025.1528154. eCollection 2025.
3

本文引用的文献

1
Global practice variation in pharmacologic thromboprophylaxis for general and gynaecological surgery: systematic review.普通外科和妇科手术中药物性血栓预防的全球实践差异:系统评价
BJS Open. 2022 Sep 2;6(5). doi: 10.1093/bjsopen/zrac129.
2
2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19.2022 年国际癌症患者静脉血栓栓塞症治疗和预防临床实践指南,包括 COVID-19 患者。
Lancet Oncol. 2022 Jul;23(7):e334-e347. doi: 10.1016/S1470-2045(22)00160-7.
3
Systematic reviews of observational studies of Risk of Thrombosis and Bleeding in General and Gynecologic Surgery (ROTBIGGS): introduction and methodology.
Aspirin for the extended prevention of venous thromboembolism: a meta-analysis and trial sequential analysis.
阿司匹林用于静脉血栓栓塞的长期预防:一项荟萃分析和试验序贯分析
Sci Rep. 2025 May 17;15(1):17213. doi: 10.1038/s41598-025-02171-z.
4
Association of coagulation-related indicators with postoperative venous thromboembolism occurrence in patients with pituitary tumors.垂体瘤患者凝血相关指标与术后静脉血栓栓塞发生的相关性
Sci Rep. 2025 May 14;15(1):16694. doi: 10.1038/s41598-025-01029-8.
5
Advances and Challenges in the Application of Novel Oral Anticoagulants for Venous Thromboembolism Prevention Following Colorectal Cancer Surgery.新型口服抗凝剂在结直肠癌手术后预防静脉血栓栓塞应用中的进展与挑战
J Gastrointest Cancer. 2025 Apr 22;56(1):104. doi: 10.1007/s12029-025-01232-w.
6
Descriptive Epidemiology of Venous Thromboembolism in Pediatric Orthopedic Patients: A National, Multicenter Study.小儿骨科患者静脉血栓栓塞的描述性流行病学:一项全国性多中心研究。
JB JS Open Access. 2025 Mar 14;10(1). doi: 10.2106/JBJS.OA.24.00143. eCollection 2025 Jan-Mar.
7
Extended pharmacological thromboprophylaxis and clinically relevant venous thromboembolism after major abdominal and pelvic surgery: international, prospective, propensity score-weighted cohort study.大型腹部和盆腔手术后延长药物性血栓预防与临床相关静脉血栓栓塞:国际前瞻性倾向评分加权队列研究
Br J Surg. 2025 Mar 4;112(3). doi: 10.1093/bjs/znaf005.
8
Comparing the efficacy and safety of thromboprophylaxis with enoxaparin versus normal saline after liver transplantation: randomized clinical trial.肝移植术后依诺肝素与生理盐水预防血栓形成的疗效和安全性比较:随机临床试验
Br J Surg. 2025 Feb 1;112(2). doi: 10.1093/bjs/znae325.
9
Reassessing the Risk of Venous Thromboembolism (VTE) Events in Women.重新评估女性静脉血栓栓塞(VTE)事件的风险
Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241305108. doi: 10.1177/10760296241305108.
10
Imaging and Biomarkers: The Assesment of Pulmonary Embolism Risk and Early Mortality.影像学和生物标志物:肺栓塞风险和早期死亡率评估。
Medicina (Kaunas). 2024 Sep 12;60(9):1489. doi: 10.3390/medicina60091489.
普通外科和妇科手术中血栓形成与出血风险的观察性研究的系统评价(ROTBIGGS):引言与方法
Syst Rev. 2021 Oct 8;10(1):264. doi: 10.1186/s13643-021-01814-2.
4
Timing of Perioperative Pharmacologic Thromboprophylaxis Initiation and its Effect on Venous Thromboembolism and Bleeding Outcomes: A Systematic Review and Meta-Analysis.围手术期药物性血栓预防开始时机及其对静脉血栓栓塞和出血结局的影响:系统评价和荟萃分析。
J Am Coll Surg. 2021 Nov;233(5):619-631.e14. doi: 10.1016/j.jamcollsurg.2021.07.687. Epub 2021 Aug 24.
5
Extended-duration thromboprophylaxis after ventral hernia repair: a risk model to predict venous thrombotic events after hospital discharge.腹外疝修补术后延长时间的血栓预防:预测出院后静脉血栓栓塞事件的风险模型。
Hernia. 2022 Jun;26(3):919-926. doi: 10.1007/s10029-021-02481-x. Epub 2021 Aug 15.
6
Prevention of Venous Thromboembolism in Gynecologic Surgery: ACOG Practice Bulletin, Number 232.妇科手术中静脉血栓栓塞的预防:美国妇产科医师学会实践公报,第232号
Obstet Gynecol. 2021 Jul 1;138(1):e1-e15. doi: 10.1097/AOG.0000000000004445.
7
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.PRISMA 2020 声明:系统评价报告的更新指南。
BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71.
8
Variations in practice of thromboprophylaxis across general surgical subspecialties: a multicentre (PROTECTinG) study of elective major surgeries.普通外科各亚专业血栓预防实践的差异:一项针对择期大手术的多中心(PROTECTinG)研究。
ANZ J Surg. 2020 Dec;90(12):2441-2448. doi: 10.1111/ans.16374. Epub 2020 Oct 30.
9
An evaluation of the timing of surgical complications following radical prostatectomy: Data from the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP).根治性前列腺切除术后手术并发症发生时间的评估:来自美国外科医师学会国家外科质量改进计划(ACS-NSQIP)的数据。
Arab J Urol. 2020 Apr 17;18(3):136-141. doi: 10.1080/2090598X.2020.1749478.
10
An International Survey on the Use of Thromboprophylaxis in Urological Surgery.泌尿科手术中血栓预防的国际调查。
Eur Urol Focus. 2021 May;7(3):653-658. doi: 10.1016/j.euf.2020.05.015. Epub 2020 Jun 16.